Dr. Scott Gottlieb, the outgoing Food and Drug Administration commissioner, about his tenure and the future of the agency. Among the issues discussed were tobacco and nicotine regulation, rules ...

Scott Gottlieb, President Trump's choice to become the next commissioner of the Food and Drug Administration, was confirmed Tuesday by the Senate. The vote was 57 to 42. Gottlieb, a physician and ...

Products regulated by the Food and Drug Administration (FDA) account for about 20 cents of every dollar of annual spending by U.S. consumers, amounting to more than $2.4 trillion in annual ...

WASHINGTON – Food and Drug Administration Commissioner Scott Gottlieb, who stood out in the Trump administration for his efforts to increase regulations around youth vaping and tobacco ...

WASHINGTON — Food and Drug Administration Commissioner Scott Gottlieb is stepping down after nearly two years leading the agency’s response to a host of public health challenges, including the ...

Scott Gottlieb. FDA Chief and Vaping Opponent Scott Gottlieb Is Leaving the Food and Drug Administration When and wherever public health conflicted with personal freedom, Gottlieb advocated for ...

America, you have a new commissioner at the Food and Drug Administration. Dr. Scott Gottlieb, a 44-year-old physician, was confirmed by the Senate this week in a 57-42 vote.

Dr. Scott Gottlieb is President Trump's choice to lead the Food and Drug Administration, according to a statement from the White House. Gottlieb is a political conservative and fellow at the ...

In an effort to make it easier for physicians to access information on increasingly targeted treatments, t | The growing market for targeted drug therapies has led the Food and Drug Administration ...

Former Food and Drug Administration (FDA) Commissioner Scott Gottlieb said a shortage of antibiotic drugs in the U.S. is the result of pharmaceutical companies not expecting a surge in demand rathe… ...

Gottlieb was interviewed by Bloomberg News' Anna Edney Dr. Scott Gottlieb , the outgoing Food and Drug Administration commissioner, about his tenure and the future of the agency. Among the issues… ...